Tenofovir Disoproxil Fumarate

Tenofovir Disoproxil Fumarate
Product Description

API - Active Pharmaceutical Ingredient

- Therapeutic Area: HIV infection and Chronic Hepatitis B
- Status: DMF (Drug Master File Ready) 

Blanver fully respects the patents’ expiration dates in all countries

Read more Show less

Blanver Farmoquimica Ltda.

  • BR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Other
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    202138-50-9
More specifications Fewer specifications

Blanver Farmoquimica Ltda.

  • BR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Other
View company profile

More Products from Blanver Farmoquimica Ltda. (2)

  • Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    Product Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    - Presentation: Plastic bottles with 30 coated tablets.  

    - Indication (Brazil Prescription Medicines): 
    1) For PrEP® (pre-exposure prophylaxis), it can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices.
    ...
  • Raloxifene Hydrochloride 60 mg

    Product Raloxifene Hydrochloride 60 mg

    - Presentation: Blisters containing 28 film-coated tablets  

    - Indication (Brazil Prescription Medicines): 
    1) For the prevention and treatment of osteoporosis;
    2) To reduce the risk of breast cancer in postmenopausal womem with osteoporosis.

    -...

Blanver Farmoquimica Ltda. resources (1)